We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+23.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.87B
Cap. Flow
% of AUM
-23.65%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$76.6M |
| 3 |
Lowe's Companies
LOW
|
+$75.4M |
| 4 |
Monster Beverage
MNST
|
+$64.6M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$114M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 3 |
Trane Technologies
TT
|
+$106M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Quest Diagnostics
DGX
$26.4B
| $12.7M | 0.08% |
111,561
-18,329
| -14% | -$1.94M |
|
277
Vanguard Small-Cap Value ETF
VBR
$37.6B
| $12.6M | 0.08% |
117,463
-6,036
| -5% | -$606K |
|
278
Salesforce
CRM
$149B
| $12.5M | 0.08% |
66,739
+38,290
| +135% | +$6.45M |
|
279
Lamar Advertising Co
LAMR
$16.2B
| $12.4M | 0.08% |
186,420
-23,778
| -11% | -$1.45M |
|
280
Broadcom
AVGO
$1.79T
| $12.2M | 0.07% |
386,050
-21,450
| -5% | -$600K |
|
|
DFS
281
DELISTED
Discover Financial Services
DFS
| $12.1M | 0.07% |
241,902
-683,181
| -74% | -$30.1M |
|
|
UCB
282
United Community Banks
UCB
$4.24B
| $12.1M | 0.07% |
602,057
-183,944
| -23% | -$3.52M |
|
|
CMD
283
DELISTED
Cantel Medical Corporation
CMD
| $11.9M | 0.07% |
269,846
-53,006
| -16% | -$1.98M |
|
284
Genuine Parts
GPC
$18B
| $11.8M | 0.07% |
135,818
+21,590
| +19% | +$1.7M |
|
285
Hancock Whitney
HWC
$6.09B
| $11.6M | 0.07% |
546,990
-148,256
| -21% | -$3.06M |
|
286
Skyworks Solutions
SWKS
$9.59B
| $11.6M | 0.07% |
90,433
-20,106
| -18% | -$2.23M |
|
287
Otis Worldwide
OTIS
$28.6B
| $11.5M | 0.07% |
+202,654
| New | +$10.5M |
|
288
Pacira BioSciences
PCRX
$1.06B
| $11.5M | 0.07% |
219,111
+216,746
| +9,165% | +$9.06M |
|
|
NVO
289
Novo Nordisk
NVO
$225B
| $11.4M | 0.07% |
349,096
-16,252
| -4% | -$519K |
|
290
Ameris Bancorp
ABCB
$5.78B
| $11.4M | 0.07% |
484,113
-137,611
| -22% | -$3.23M |
|
291
Netflix
NFLX
$307B
| $11.4M | 0.07% |
250,720
-25,120
| -9% | -$1.07M |
|
292
Simmons First National
SFNC
$3.35B
| $11.3M | 0.07% |
662,924
-181,697
| -22% | -$3.11M |
|
293
Caterpillar
CAT
$384B
| $11.2M | 0.07% |
88,431
-8,457
| -9% | -$1M |
|
294
Principal Financial Group
PFG
$24.2B
| $11.2M | 0.07% |
269,083
+30,478
| +13% | +$1.11M |
|
|
FMBI
295
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $11.1M | 0.07% |
832,042
-246,026
| -23% | -$3.26M |
|
296
Equinix
EQIX
$103B
| $11M | 0.07% |
15,732
+14,125
| +879% | +$9.55M |
|
297
AMN Healthcare
AMN
$1.33B
| $11M | 0.07% |
243,305
-58,290
| -19% | -$2.79M |
|
298
Gen Digital
GEN
$16.4B
| $10.9M | 0.07% |
549,987
+486,774
| +770% | +$9.91M |
|
299
Xerox
XRX
$349M
| $10.9M | 0.07% |
710,068
+1,243
| +0.2% | +$21.4K |
|
|
LMNX
300
DELISTED
Luminex Corp
LMNX
| $10.8M | 0.07% |
333,063
-287,918
| -46% | -$9.11M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.
- Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
- Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
- Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
- Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
- Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
- Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.